Vaxart, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
REGNRegeneron Pharmaceuticals, Inc. -2.06%570.502.7%$657.69m
GILDGilead Sciences, Inc. -1.72%58.981.0%$568.85m
AMGNAmgen, Inc. -2.54%217.791.3%$564.41m
VRTXVertex Pharmaceuticals, Inc. -1.05%209.961.9%$527.70m
MRNAModerna, Inc. -5.96%66.460.0%$424.13m
ILMNIllumina, Inc. -3.18%311.503.5%$409.12m
EXASEXACT Sciences Corp. -2.32%128.0820.7%$287.32m
ALXNAlexion Pharmaceuticals, Inc. -4.03%115.172.0%$258.07m
BIIBBiogen, Inc. -3.59%246.141.7%$254.66m
NVAXNovavax, Inc. -8.73%81.7796.5%$250.03m
BNTXBioNTech SE -7.48%77.680.0%$195.69m
SGENSeagen Inc. -0.07%196.796.0%$150.33m
SRNESorrento Therapeutics, Inc. -7.67%7.121.4%$139.73m
CRSPCRISPR Therapeutics AG -3.17%95.010.6%$122.31m
TXG10X Genomics, Inc. -0.64%142.010.0%$103.36m

Company Profile

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.